secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2024-12-03T23:59:59+00:00
Accession:  0001493152-24-048490
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beyond Air receives CE Mark for LungFit PH in Europe; triggers $1M milestone payment from Getz Healthcare
--------------------------------------------------------------------------------

- CE mark approval allows Beyond Air to market LungFit PH in the European Union and other recognizing countries.
- $1 million milestone payment triggered from Asia-Pacific partner Getz Healthcare upon CE mark certification.
- Indications include hypoxic respiratory failure in infants >34 weeks gestation and peri-/post-operative pulmonary hypertension in adults and children 0-17.
- Partnership with Getz covers Australia, New Zealand, Thailand, Philippines, Taiwan, Hong Kong, Malaysia, Pakistan, Singapore, and Vietnam.
- LungFit PH generates NO from ambient air via Ionizer technology, eliminating tanks and reducing hospital carbon footprint.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000149315224048490/0001493152-24-048490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000149315224048490/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-048490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer